関連する実験動画
Updated: Feb 26, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
一次診療のための潰瘍性大腸炎に関する最新情報
Sarah Bolander1, Kimberly Carter, Tiffany Cooke
1Sarah Bolander is an assistant professor at Northern Arizona University in Phoenix, AZ. Kimberly Carter is an associate professor and director of clinical education at Midwestern University in Glendale, AZ. Tiffany Cooke is an assistant clinical professor at Northern Arizona University. Nicole Hamilton is an assistant professor at Midwestern University. The authors have disclosed no potential conflicts of interest, financial or otherwise.
慢性炎症性腸疾患(IBD)である潰瘍性大腸炎(UC)は、効果的な管理のために早期認識が必要です。生物学的製剤や低分子化合物を含む治療法の進歩は、この疾患を持つ患者にとって改善された選択肢を提供します。
科学分野:
- 消化器病学
- 免疫学
背景:
- 潰瘍性大腸炎(UC)は、結腸と直腸の炎症を引き起こす慢性炎症性腸疾患(IBD)です。
- 血便を伴う下痢や腹痛などの症状は、生活の質を著しく低下させます。
研究 の 目的:
- 潰瘍性大腸炎の早期認識の重要な必要性を強調すること。
- 最近の治療法の進歩と個別化された治療選択の重要性について議論すること。
主な方法:
- 潰瘍性大腸炎管理に関する現行の文献のレビュー。
- 新規の薬理学的および非薬理学的介入の分析。
- 患者ケアへの集学的アプローチの重視。
主要な成果:
- 新規生物学的製剤、低分子化合物、バイオシミラーにより、治療へのアクセスが拡大しました。
- 治療選択は、疾患の重症度、部位、患者のニーズに合わせて個別化されます。
- 補助療法と集学的チームが、包括的なケアを強化します。
結論:
- 寛解の誘発・維持、粘膜治癒の促進、疾患進行の予防には、治療の最適化が鍵となります。
- 潰瘍性大腸炎患者の長期的な予後を改善するには、協調的で集学的なアプローチが不可欠です。
さらに関連する動画
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
08:51Murine Appendectomy Model of Chronic Colitis Associated Colorectal Cancer by Precise Localization of Caecal Patch
Published on: August 24, 2019
関連する概念動画
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD: